EVOTEC has acquired Cyprotex PLC

Target
Company Name
Target
Country
Description

Evotec acquired 100 percent of the outstanding shares of Cyprotex in an all-cash transaction valued at £55.7 million effective December 15, 2016.

Global M&A Offices
Brown Gibbons Lang & Company (Global M&A USA)
Global M&A Advisory Advisor